Benzinga's Top Downgrades
Analysts at Barclays downgraded Bristol-Myers Squibb Company (NYSE: BMY) from “overweight” to “equal-weight.” The target price for Bristol-Myers Squibb has been lowered from $65 to $46. Bristol-Myers Squibb's shares closed at $48.12 yesterday.
Analysts at Raymond James downgraded Harley-Davidson (NYSE: HOG) from “strong buy” to “market perform” and removed the price target of $84. Harley-Davidson's shares closed at $70.33 yesterday.
Baird downgraded U.S. Bancorp (NYSE: USB) from “outperform” to “neutral.” The price target for U.S. Bancorp is set to $44. U.S. Bancorp's shares closed at $43.34 yesterday.
Credit Suisse downgraded Hormel Foods (NYSE: HRL) from “outperform” to “neutral.” Hormel's shares closed at $49.19 yesterday.
Latest Ratings for BMY
|Oct 2016||Hilliard Lyons||Upgrades||Neutral||Long-Term Buy|
|Oct 2016||Credit Suisse||Maintains||Neutral|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.